The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of 16 medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in April.
Nine decisions were released for prosthesis:
- EVORA, EVORA SP, EVORA LIS, EVORA GRIP, EVORA GRIP 3P (without cement), acetabular cup with double mobility (application for registration, approved)
- PROFEMUR R, femoral stem (application for registration, approved)
- PROFEMUR Z, femoral stem (application for registration, approved)
- PROFEMUR AM, femoral stem (application for registration, rejected due to insufficient expected benefit)
- STRATOS (without cement), acetabular cup with double mobility (application for registration, rejected due to insufficient expected benefit)
Three decisions were released for neurostimulators:
- PROCLAIM DRG, dorsal root ganglion stimulator, (application for registration, approved)
- PRECISION SPECTRA, implantable system for medullary neurostimulation (renewal of registration, approved)
- PRECISION MONTAGE MRI, implantable system for medullary neurostimulation (renewal of registration, approved)
Four decisions were released for other devices:
- TADIMDILUANT 3ml, sterile sodium chloride solution (application for registration, approved)
- TADIMDILUANT 1ml, sterile sodium chloride solution (application for registration, approved)
- OSTENIL PLUS, viscoelastic solution (application for registration, rejected due to insufficient expected benefit)
- DEFLUX, ureteral implant (renewal of registration, approved)
See list of decisions in French here.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.